Your browser doesn't support javascript.
loading
Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer.
Fehrenbacher, Louis; von Pawel, Joachim; Park, Keunchil; Rittmeyer, Achim; Gandara, David R; Ponce Aix, Santiago; Han, Ji-Youn; Gadgeel, Shirish M; Hida, Toyoaki; Cortinovis, Diego L; Cobo, Manuel; Kowalski, Dariusz M; De Marinis, Filippo; Gandhi, Mayank; Danner, Bradford; Matheny, Christina; Kowanetz, Marcin; He, Pei; Felizzi, Federico; Patel, Hina; Sandler, Alan; Ballinger, Marcus; Barlesi, Fabrice.
Afiliação
  • Fehrenbacher L; Kaiser Permanente Medical Center, Vallejo, California. Electronic address: louis.fehrenbacher@gmail.com.
  • von Pawel J; Asklepios Fachkliniken München-Gauting, Gauting, Germany.
  • Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Rittmeyer A; Pulmonary Clinic Immenhausen, Immenhausen, Germany.
  • Gandara DR; University of California Davis Comprehensive Cancer Center, Sacramento, California.
  • Ponce Aix S; University Hospital 12 de Octubre, Madrid, Spain.
  • Han JY; National Cancer Center, Goyang, Republic of Korea.
  • Gadgeel SM; University of Michigan, Ann Arbor, Michigan.
  • Hida T; Aichi Cancer Center Hospital, Nagoya, Japan.
  • Cortinovis DL; University Hospital San Gerardo, Monza, Italy.
  • Cobo M; Carlos Haya University Regional Málaga Hospital, Málaga, Spain.
  • Kowalski DM; The Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland.
  • De Marinis F; European Institute of Oncology, Milan, Italy.
  • Gandhi M; Genentech, Inc., South San Francisco, California.
  • Danner B; Genentech, Inc., South San Francisco, California.
  • Matheny C; Genentech, Inc., South San Francisco, California.
  • Kowanetz M; Genentech, Inc., South San Francisco, California.
  • He P; Genentech, Inc., South San Francisco, California.
  • Felizzi F; Genentech, Inc., South San Francisco, California.
  • Patel H; Genentech, Inc., South San Francisco, California.
  • Sandler A; Genentech, Inc., South San Francisco, California.
  • Ballinger M; Genentech, Inc., South San Francisco, California.
  • Barlesi F; Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Marseille, France.
J Thorac Oncol ; 13(8): 1156-1170, 2018 08.
Article em En | MEDLINE | ID: mdl-29777823
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Docetaxel / Neoplasias Pulmonares / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male Idioma: En Revista: J Thorac Oncol Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Docetaxel / Neoplasias Pulmonares / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male Idioma: En Revista: J Thorac Oncol Ano de publicação: 2018 Tipo de documento: Article